2026
ICD-10-CM
Diagnosis
Code

T45.AX5D Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter

  • Billable
  • POA Exempt
  • 2025–2026

T45.AX5D is a billable/specific and POA-exempt diagnosis code from the 2026 ICD-10-CM used to classify the following condition: Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter.

Versions

  1. 2026

    No changes

  2. 2025

    New code